.Pharmacolibrary.Drugs.N_NervousSystem.N06B_PsychostimulantsAgentsUsedForAdhdAndNootropics.N06BC01_Caffeine.Caffeine .Pharmacolibrary.Drugs.N_NervousSystem.N06B_PsychostimulantsAgentsUsedForAdhdAndNootropics.N06BC01_Caffeine.Caffeine| name: | Caffeine |
| ATC code: | N06BC01 | route: | oral |
| n-compartments | 1 |
Caffeine is a central nervous system stimulant belonging to the methylxanthine class. It is widely consumed in beverages such as coffee, tea, and soft drinks and is used medically to treat apnea of prematurity in neonates. It is an approved drug and also used as a psychoactive substance for reducing fatigue and improving mental alertness.
Pharmacokinetic parameters reported for healthy adult subjects after single oral administration of 200 mg caffeine.
Seng, KY, et al., & Lim, CL (2009). Population pharmacokinetics of caffeine in healthy male adults using mixed-effects models. Journal of clinical pharmacy and therapeutics 34(1) 103–114. DOI:10.1111/j.1365-2710.2008.00976.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/19125908
Cornelis, MC, et al., & Chasman, DI (2015). Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Molecular psychiatry 20(5) 647–656. DOI:10.1038/mp.2014.107 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25288136
Zandvliet, AS, et al., & Beijnen, JH (2005). Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. Basic & clinical pharmacology & toxicology 96(1) 71–79. DOI:10.1111/j.1742-7843.2005.pto960111.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/15667599